Synlait Milk

Craigs Investment Partners head of wealth research Mark Lister says “You’ve had shareholders generally looking for more growth ideas"

High flyers A2 Milk, Synlait and Xero dominate share market performance

Mon 16 Oct

A monster week for global and local political, economic and corporate news

Harbour director Oyvinn Rimer says CFDA approval removes a major risk from investing in A2

A2 knocking at the door of the Top 10, ASX 100 indices

Mon 2 Oct

CFDA approval should spur A2's on-the-ground sales in China.

Craigs Investment Partners head of wealth research Mark Lister feels "Metro Performance Glass has missed the boat to some degree on this strong few years we’ve had"

Milk and honey win as window maker crashes

Mon 2 Oct 1

QSBO a likely pointer to political impact on business.

Synlait chief executive John Penno said "We are now in a stronger position for future applications of other Synlait customers"

Synlait Milk, a2 shares at record high as CFDA registration underpins China strategy

Thu 28 Sep 10

The products will continue to have market access in 2018 when China tightens its rules.

Synlait Milk managing director John Penno says “There’s no question they will not be the same margins as infant formula"

Synlait aims to move up the value chain to consumer goods

Mon 25 Sep 1

Synlait looks beyond its lucrative infant formula business

Synlait Milk managing director John Penno says his company is operating at capacity

Synlait points to likely infant formula demand lift in China next year

Wed 20 Sep

Navigating short-term capacity constraints.

Pages

Subscribe to Synlait Milk